|
Posted 26 July 2005
Transgene: Crossed APPV717I
(London) with PS1 (n-/-).
Mutation: APP V717I (London)
Promoter: Thy 1
Mouse strain: FVB/N (Crl)
Neuropathological Analysis:
In bigenic mice the neuronal absence of PS1 effectively prevented amyloid pathology,
even in mice that were 18 months old, whereas single APP (V717I) mice develop amyloid
pathology at 10-12 months. LTP also was rescued in bigenic mice but not the cognitive
defect of APP(V717I) mice.
Behavioral
normal
Mice can be made available for academic collaboration under MTA with KULeuven-R&D.
For information on these mice, please contact:
Paul Van Dun
Director - KULeuvenR&D
Groot Begijnhof 59
B-3000 Leuven Belgium
tel +32 16 326508
fax +32 16 326515
Email: Paul.Vandun@lrd.kuleuven.ac.be
Web site: http://www.kuleuven.ac.be/lrd
Primary:
Dewachter I, Reversé D, Caluwaerts N, Ris L, Kuipéri C, Van den Haute C, Spittaels
K, Umans L, Serneels L, Thiry E, Moechars D, Mercken M, Godaux E, Van Leuven F.
Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects
hippocampal long-term potentiation but not a cognitive defect of amyloid precursor
protein [V717I] transgenic mice. J Neurosci. 2002 May 1 ; 22(9):3445-53.
Abstract
Associated:
Van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van Den Haute C, Mercken
M, Moechars D, Laenen I, Kuiperi C, Bruynseels K, Tesseur I, Loos R, Vanderstichele
H, Checler F, Sciot R, Van Leuven F. Prominent cerebral Amyloid Angioplathy in APP/London
transgenic mice. Am J Pathol (2000) 157:1283-1298.
Abstract
Moechars D, Dewachter I, Lorent K, Reversé D, Baekelandt V, Naidu A, Tesseur I,
Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, Van Leuven F. Early phenotypic
changes in transgenic mice that overexpress different mutants of amyloid precursor
protein in brain. J Biol Chem. 1999; 274 (10): 6483-92.
Abstract.
Ris L, Dewachter I, Reverse D, Godaux E, Van Leuven F. Capacitative calcium entry
induces hippocampal long term potentiation in the absence of presenilin-1. J Biol
Chem. 2003; 278(45):44393-9. Abstract.
|